Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NuPower JV

Re: NuPower JV

in response to by
posted on Jun 18, 2008 06:50AM

<If TPL's valuation is higher due to cash on hand and their Seaforth product line than perhaps the revenue TPL could potentially receive from our JV will bring PTSC's valuation more in line. I'm sure TPL had a hand in determing the potential licensing value of NuPowers portfolio. >

I agree, but IMHO is it the difficultly of applying a valuation on IP that makes something like Nupower necessary. As long as there is agreement that the IP has a similar potential to what TPL has, that will do. It might be alot easier to equate IP potential than to assign a current $ value to what TPL has. Does that make sense? Opty

Share
New Message
Please login to post a reply